Diabetes

Study identifies target for diabetes drug

New research from the University of Cincinnati (UC) points to the naturally produced protein apolipoprotein A-IV (apoA-IV) as a potential target for a new diabetes therapeutic.

May 21, 2012
popularity 5 / 5 (1) | comments 0 | with audio podcast

Glucagon, GLP-1 co-infusion can reduce appetite

(HealthDay)—Co-infusion of glucagon and glucagon-like peptide 1 (GLP-1) correlates with a reduction in appetite, and GLP-1 protects against glucagon-induced hyperglycemia in healthy volunteers, according ...

Jun 25, 2014
popularity not rated yet | comments 0

Oxygen treatment beneficial in diabetes-prone mice

(HealthDay) -- Hyperbaric oxygen treatment of a preclinical diabetes mouse model reduces the incidence of diabetes and preserves insulin-producing β-cells, according to a study published online May 7 ...

May 08, 2012
popularity not rated yet | comments 0 | with audio podcast